2,450
Views
92
CrossRef citations to date
0
Altmetric
Review

Trial watch

Dendritic cell-based interventions for cancer therapy

, , , , , , , , , & show all
Article: e25771 | Received 15 Jul 2013, Accepted 16 Jul 2013, Published online: 29 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (27)

Michal Hensler, Jana Rakova, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Peter Holicek, Marek Hraska, Tereza Hrnciarova, Pavla Kadlecova, Andreu Schoenenberger, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Jana Drozenova, Jan Laco, Rudolf Horvath, Michal Podrazil, Guo Hongyan, Tomas Brtnicky, Michal J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, Abhishek D. Garg, David Cibula, Jirina Bartunkova, Radek Spisek & Jitka Fucikova. (2022) Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines. OncoImmunology 11:1.
Read now
Sidhant Jain & Sahil Kumar. (2020) Cancer immunotherapy: dawn of the death of cancer?. International Reviews of Immunology 39:5, pages 205-222.
Read now
Giorgio Frega, Qi Wu, Julie Le Naour, Erika Vacchelli, Lorenzo Galluzzi, Guido Kroemer & Oliver Kepp. (2020) Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. OncoImmunology 9:1.
Read now
Johnie Hodge, Fang Wang, Junfeng Wang, Qing Liu, Fatma Saaoud, Yuzhen Wang, Udai P. Singh, Hexin Chen, Ming Luo, Walden Ai & Daping Fan. (2020) Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer. OncoImmunology 9:1.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Jinyu Li, Adila Aipire, Huixin Zhao, Pengfei Yuan & Jinyao Li. (2019) Pleurotus ferulae polysaccharides improve the antitumor efficacy of therapeutic human papillomavirus dendritic cell-based vaccine. Human Vaccines & Immunotherapeutics 15:3, pages 611-619.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now
Susanne M. Rittig, Maik Haentschel, Katrin J. Weimer, Annkristin Heine, Martin R. Müller, Wolfram Brugger, Marius S. Horger, Olga Maksimovic, Arnulf Stenzl, Ingmar Hoerr, Hans-Georg Rammensee, Tobias A. Holderried, Lothar Kanz, Steve Pascolo & Peter Brossart. (2016) Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy. OncoImmunology 5:5.
Read now
Kristina Iribarren, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Špíšek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. OncoImmunology 5:3.
Read now
Erika Vacchelli, Fernando Aranda, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology 5:2.
Read now
Fernando Aranda, Aitziber Buqué, Norma Bloy, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Adoptive cell transfer for oncological indications. OncoImmunology 4:11.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Daphné Benteyn, Carlo Heirman, Aude Bonehill, Kris Thielemans & Karine Breckpot. (2015) mRNA-based dendritic cell vaccines. Expert Review of Vaccines 14:2, pages 161-176.
Read now
Irena Adkins, Jitka Fucikova, Abhishek D Garg, Patrizia Agostinis & Radek Špíšek. (2014) Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. OncoImmunology 3:12.
Read now
Lorenzo Galluzzi, Guido Kroemer & Alexander Eggermont. (2014) Novel immune checkpoint blocker approved for the treatment of advanced melanoma. OncoImmunology 3:11.
Read now
Norma Bloy, Jonathan Pol, Fernando Aranda, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fučíková, Jérôme Galon, Eric Tartour, Radek Spisek, Madhav V. Dhodapkar, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: Dendritic cell-based anticancer therapy. OncoImmunology 3:11.
Read now
Norma Bloy, Jonathan Pol, Gwenola Manic, Ilio Vitale, Alexander Eggermont, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch: Radioimmunotherapy for oncological indications. OncoImmunology 3:9.
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès-Fridman, Eric Tartour, Eugene P Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 3:10.
Read now
Sabina Antonela Antoniu, Gabriel Dimofte & Didona Ungureanu. (2014) Immune therapies for malignant mesothelioma. Expert Review of Anticancer Therapy 14:8, pages 965-973.
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Jan Henrik ter Meulen, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:6.
Read now
Erika Vacchelli, Fernando Aranda, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch. OncoImmunology 3:6.
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:5.
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:4.
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:2.
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:12.
Read now
Michaela Semeraro, Erika Vacchelli, Alexander Eggermont , Jerome Galon, L Zitvogel, G Kroemer & Lorenzo Galluzzi. (2013) Trial Watch: Lenalidomide-based immunochemotherapy. OncoImmunology 2:11.
Read now

Articles from other publishers (65)

Christopher Cultrara, Christopher Uhl, Kenneth Kirby, Essam Abed Elrazaq, Amelia Zellander, David W Andrews, Charles B Scott, Lorenzo Galluzzi, Mark A Exley & Jenny Zilberberg. (2023) A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma. Journal for ImmunoTherapy of Cancer 11:8, pages e006880.
Crossref
Nasim Adabi, Safoora Pordel, Mohammad Ali Rezaee, Fatemeh Sadat Shobeiri & Saeideh Sadat Shobeiri. (2023) Application of CAR‐T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment. The Journal of Gene Medicine 25:5.
Crossref
Simin Li, Yichang Chen, Ruolin Ma, Ye Du & Bing Han. (2023) Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses. Frontiers in Pharmacology 14.
Crossref
Pengfei Yuan, Litong Liu, Adila Aipire, Yanan Zhao, Shanshan Cai, Linjia Wu, Xiaofei Yang, Alimu Aimaier, Jun Lu & Jinyao Li. (2023) Evaluation and mechanism of immune enhancement effects of Pleurotus ferulae polysaccharides-gold nanoparticles. International Journal of Biological Macromolecules 227, pages 1015-1026.
Crossref
Md. Selim Ahmed, Md Jamal Uddin, Muhammad Jahangir Hossen, Md. Ataur Rahman, Md. Mohibbullah, Md. Abdul Hannan & Jae-Suk Choi. (2022) Dendritic Cells (DCs)-Based Cancer Immunotherapy: A Review on the Prospects of Medicinal Plants and Their Phytochemicals as Potential Pharmacological Modulators. Applied Sciences 12:19, pages 9452.
Crossref
Israt S. Alam, Travis M. Shaffer & Sanjiv S. Gambhir. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology 15 59 .
Daniela Lobenwein, Florian Kocher, Stephan Dobner, Can Gollmann-Tepeköylü & Johannes Holfeld. (2021) Cardiotoxic mechanisms of cancer immunotherapy – A systematic review. International Journal of Cardiology 323, pages 179-187.
Crossref
Muhammad Sadeqi Nezhad, Alexander Seifalian, Nader Bagheri, Sajad Yaghoubi, Mohammad Hossein Karimi & Meghdad Adbollahpour-Alitappeh. (2020) Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?. Frontiers in Immunology 11.
Crossref
Jitka Fucikova, Oliver Kepp, Lenka Kasikova, Giulia Petroni, Takahiro Yamazaki, Peng Liu, Liwei Zhao, Radek Spisek, Guido Kroemer & Lorenzo Galluzzi. (2020) Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death & Disease 11:11.
Crossref
Shuqin Xu, Kunpeng Yang, Rose Li & Lu Zhang. (2020) mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection. International Journal of Molecular Sciences 21:18, pages 6582.
Crossref
Akihiro Matsumoto, Maho Asuka, Yuki Takahashi & Yoshinobu Takakura. (2020) Antitumor immunity by small extracellular vesicles collected from activated dendritic cells through effective induction of cellular and humoral immune responses. Biomaterials 252, pages 120112.
Crossref
Yanling Liu, Ping Xu, Huan Liu, Chunjuan Fang, Haihe Guo, Xiaoyan Chen, Manman Tan, Yujuan Zhang & Weiping Min. (2020) Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model. International Journal of Oncology 57:2, pages 587-597.
Crossref
Yeshu Wang, Qunfang Zhang, Yuchao Chen, Chun-Ling Liang, Huazhen Liu, Feifei Qiu & Zhenhua Dai. (2020) Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomedicine & Pharmacotherapy 121, pages 109570.
Crossref
Sheila Spada & Lorenzo Galluzzi. 2020. Extracellular vesicles. Extracellular vesicles xv xviii .
Lenka Kasikova, Michal Hensler, Iva Truxova, Petr Skapa, Jan Laco, Lucie Belicova, Ivan Praznovec, Sarka Vosahlikova, Michael J. Halaska, Tomas Brtnicky, Lukas Rob, Jiri Presl, Jan Kostun, Isabelle Cremer, Ales Ryska, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek & Jitka Fucikova. (2019) Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Beatris Mastelic-Gavillet, Klara Balint, Caroline Boudousquie, Philippe O. Gannon & Lana E. Kandalaft. (2019) Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results. Frontiers in Immunology 10.
Crossref
Dag Heiro Yi, Nadine Stetter, Kjerstin Jakobsen, Roland Jonsson & Silke Appel. (2018) 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapy. Cancer Immunology, Immunotherapy 67:10, pages 1611-1620.
Crossref
Phapanin Charoenphol, Katie Oswalt & Corey J. Bishop. (2018) Therapeutics incorporating blood constituents. Acta Biomaterialia 73, pages 64-80.
Crossref
Verónica Guerra CevallosSolange Núñez-GonzálezEstefanía OchoaCamilo FélixDaniel Simancas Racines. (2018) Imnuno-Oncología: Recuento Histórico y Fundamentos Básicos.. Oncología (Ecuador), pages 62-72.
Crossref
Laurence Chaperot, Olivier Manches & Caroline Aspord. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Jitka Fucikova, Michal Podrazil, Ladislav Jarolim, Pavla Bilkova, Michal Hensler, Etienne Becht, Zdenka Gasova, Jana Klouckova, Jana Kayserova, Rudolf Horvath, Anna Fialova, Katerina Vavrova, Klara Sochorova, Daniela Rozkova, Radek Spisek & Jirina Bartunkova. (2017) Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer. Cancer Immunology, Immunotherapy 67:1, pages 89-100.
Crossref
Tanja Lövgren, Dhifaf Sarhan, Iva Truxová, Bhavesh Choudhary, Roeltje Maas, Jeroen Melief, Maria Nyström, Ulrika Edbäck, Renee Vermeij, Gina Scurti, Michael Nishimura, Giuseppe Masucci, Alex Karlsson-Parra, Andreas Lundqvist, Lars Adamson & Rolf Kiessling. (2017) Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists. Cancer Immunology, Immunotherapy 66:10, pages 1333-1344.
Crossref
Jing Zhou, Yufeng Xi, Xiyan Mu, Rongce Zhao, Hongdou Chen, Li Zhang, Yang Wu & Qiu Li. (2017) Antitumor immunity induced by VE-cadherin modified DC vaccine. Oncotarget 8:40, pages 67369-67379.
Crossref
Adila Aipire, Jinyu Li, Pengfei Yuan, Jiang He, Yelang Hu, Lu Liu, Xiaoli Feng, Yijie Li, Fuchun Zhang, Jianhua Yang & Jinyao Li. (2017) Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine. Scientific Reports 7:1.
Crossref
Erika Takacs, Pal Boto, Emilia Simo, Tamas I. Csuth, Bianka M. Toth, Hadas Raveh-Amit, Attila Pap, Elek G. Kovács, Julianna Kobolak, Szilvia Benkö, Andras Dinnyes & Istvan Szatmari. (2017) Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3 . The Journal of Immunology 198:1, pages 239-248.
Crossref
O. V. Markov, N. L. Mironova, E. V. Shmendel, M. A. Maslov & M. A. Zenkova. (2017) Systemic delivery of complexes of melanoma RNA with mannosylated liposomes activates highly efficient murine melanoma-specific cytotoxic T cells in vivo. Molecular Biology 51:1, pages 102-107.
Crossref
I. Truxova, M. Hensler, P. Skapa, M.J. Halaska, J. Laco, A. Ryska, R. Spisek & J. Fucikova. 2017. 115 156 .
N. Khranovska, O. Skachkova, V. Sovenko, P. Sydor, M. Inomistova & V. Melnyk. (2016) Phenotypical and functional properties of generated dendritic cells in lung cancer patients. Cell and Organ Transplantology 4:2, pages 162-166.
Crossref
Anke Vanderstraeten, Sandra Tuyaerts, Tina Everaert, Rieta Van Bree, Godelieve Verbist, Cathérine Luyten & Frederic Amant. (2016) In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer. International Journal of Molecular Sciences 17:9, pages 1525.
Crossref
Masatoshi Hirayama & Yasuharu Nishimura. (2016) The present status and future prospects of peptide-based cancer vaccines. International Immunology 28:7, pages 319-328.
Crossref
Jinyu Li, Jinyao Li, Adila Aipire, JiaoJiao Luo, Pengfei Yuan & Fuchun Zhang. (2016) The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine. Vaccine 34:31, pages 3568-3575.
Crossref
Ho Won Lee, Prakash Gangadaran, Senthilkumar Kalimuthu & Byeong-Cheol Ahn. (2016) Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells . BioMed Research International 2016, pages 1-10.
Crossref
Xiuyan Wang & Isabelle Rivière. (2016) Clinical manufacturing of CAR T cells: foundation of a promising therapy. Molecular Therapy - Oncolytics 3, pages 16015.
Crossref
Edward J. Moticka. 2016. A Historical Perspective on Evidence-Based Immunology. A Historical Perspective on Evidence-Based Immunology 329 339 .
Michael Gutknecht, Julian Geiger, Simone Joas, Daniela Dörfel, Helmut R Salih, Martin R Müller, Frank Grünebach & Susanne M Rittig. (2015) The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells. Cell Communication and Signaling 13:1.
Crossref
Sreejit Parameswaran, Muhammad Khalil, Khawaja Ashfaque Ahmed, Rajendra K. Sharma & Jim Xiang. (2015) Enhanced Protective Immunity Derived from Dendritic Cells with Phagocytosis of CD40 Ligand Transgene-engineered Apoptotic Tumor Cells via Increased Dendritic Cell Maturation. Tumori Journal 101:6, pages 637-643.
Crossref
Saeed Daneshmandi, Ali Akbar Pourfathollah, Mohammad Hossein Karimi & Modjtaba Emadi-Baygi. (2015) PDL-1/PDL-2 blockade in mice dendritic cells by RNAi techniques to induce antitumor immunity. Immunotherapy 7:11, pages 1145-1158.
Crossref
Gabriela A. Pizzurro, Ivana J. Tapia, Leonardo Sganga, Osvaldo L. Podhajcer, José Mordoh & María M. Barrio. (2015) Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine. Cancer Immunology, Immunotherapy 64:11, pages 1393-1406.
Crossref
Jieming Zeng, Chunxiao Wu & Shu Wang. (2015) Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells. Scientific Reports 5:1.
Crossref
Aurélie Collignon, Adriana Teodora Perles-Barbacaru, Stéphane Robert, Françoise Silvy, Emmanuelle Martinez, Isabelle Crenon, Sébastien Germain, Stéphane Garcia, Angèle Viola, Dominique Lombardo, Eric Mas & Evelyne Béraud. (2015) A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination. Oncotarget 6:27, pages 23462-23479.
Crossref
L. Apetoh, S. Ladoire, G. Coukos & F. Ghiringhelli. (2015) Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?. Annals of Oncology 26:9, pages 1813-1823.
Crossref
Oleg V. Markov, Nadezhda L. Mironova, Elena V. Shmendel, Roman N. Serikov, Nina G. Morozova, Mikhail A. Maslov, Valentin V. Vlassov & Marina A. Zenkova. (2015) Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model. Journal of Controlled Release 213, pages 45-56.
Crossref
Oliver Kepp, Michaela Semeraro, José Manuel Bravo-San Pedro, Norma Bloy, Aitziber Buqué, Xing Huang, Heng Zhou, Laura Senovilla, Guido Kroemer & Lorenzo Galluzzi. (2015) eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology 33, pages 86-92.
Crossref
Jinyao Li, Jinyu Li & Fuchun Zhang. (2015) The immunoregulatory effects of Chinese herbal medicine on the maturation and function of dendritic cells. Journal of Ethnopharmacology 171, pages 184-195.
Crossref
Michal Podrazil, Rudolf Horvath, Etienne Becht, Daniela Rozkova, Pavla Bilkova, Klara Sochorova, Hana Hromadkova, Jana Kayserova, Katerina Vavrova, Jan Lastovicka, Petra Vrabcova, Katerina Kubackova, Zdenka Gasova, Ladislav Jarolim, Marek Babjuk, Radek Spisek, Jirina Bartunkova & Jitka Fucikova. (2015) Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. Oncotarget 6:20, pages 18192-18205.
Crossref
Encouse B Golden, Arpit Chhabra, Abraham Chachoua, Sylvia Adams, Martin Donach, Maria Fenton-Kerimian, Kent Friedman, Fabio Ponzo, James S Babb, Judith Goldberg, Sandra Demaria & Silvia C Formenti. (2015) Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. The Lancet Oncology 16:7, pages 795-803.
Crossref
Philipp Schuster, Sabrina Thomann, Maren Werner, Jörg Vollmer & Barbara Schmidt. (2015) A subset of human plasmacytoid dendritic cells expresses CD8α upon exposure to herpes simplex virus type 1. Frontiers in Microbiology 6.
Crossref
Susanne V. Schmidt, Stefanie Seibert, Barbara Walch-Rückheim, Benjamin Vicinus, Eva-Maria Kamionka, Jennifer Pahne-Zeppenfeld, Erich-Franz Solomayer, Yoo-Jin Kim, Rainer M. Bohle & Sigrun Smola. (2015) RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation. Oncotarget 6:11, pages 8635-8647.
Crossref
Michaela SharpeNatalie Mount. (2015) Genetically modified T cells in cancer therapy: opportunities and challenges. Disease Models & Mechanisms 8:4, pages 337-350.
Crossref
Maxwell Omabe, Shahid Ahmed, Amer Sami, Yufeng Xie, Min Tao & Jim Xiang. (2015) HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy. World Journal of Vaccines 05:02, pages 106-128.
Crossref
Aintzane Zabaleta, Delia D'Avola, Itziar Echeverria, Diana Llopiz, Leyre Silva, Lorea Villanueva, José Ignacio Riezu-Boj, Esther Larrea, Alexander Pereboev, Juan José Lasarte, Iago Rodriguez-Lago, Mercedes Iñarrairaegui, Bruno Sangro, Jesús Prieto & Pablo Sarobe. (2015) Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection. Molecular Therapy - Methods & Clinical Development 2, pages 15006.
Crossref
Gregory T. Wolf, Douglas B. Chepeha, Emily Bellile, Ariane Nguyen, Daffyd Thomas & Jonathan McHugh. (2015) Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: A preliminary study. Oral Oncology 51:1, pages 90-95.
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Enrique Vacas-Córdoba, Núria Climent, Francisco J De La Mata, Montserrat Plana, Rafael Gómez, Marjorie Pion, Felipe García & Maria Ángeles Muñoz-Fernández. (2014) Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation. Nanomedicine 9:17, pages 2683-2702.
Crossref
Carlton L Schwab, Diana P English, Dana M Roque, Monica Pasternak & Alessandro D Santin. (2014) Past, present and future targets for immunotherapy in ovarian cancer. Immunotherapy 6:12, pages 1279-1293.
Crossref
Patrizia Stoitzner, Sandra Schaffenrath, Christoph H. Tripp, Daniela Reider, Kerstin Komenda, Barbara Del Frari, Gabriel Djedovic, Susanne Ebner & Nikolaus Romani. (2014) Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors . Experimental Dermatology 23:12, pages 909-915.
Crossref
Kartik Sehgal, Kavita M. Dhodapkar & Madhav V. Dhodapkar. (2014) Targeting human dendritic cells in situ to improve vaccines. Immunology Letters 162:1, pages 59-67.
Crossref
Laura Senovilla, Fernando Aranda, Lorenzo Galluzzi & Guido Kroemer. (2014) Impact of myeloid cells on the efficacy of anticancer chemotherapy. Current Opinion in Immunology 30, pages 24-31.
Crossref
Ronald Rooke. (2014) Can calcium signaling be harnessed for cancer immunotherapy?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:10, pages 2334-2340.
Crossref
Sandra Van Lint, Sofie Wilgenhof, Carlo Heirman, Jurgen Corthals, Karine Breckpot, Aude Bonehill, Bart Neyns & Kris Thielemans. (2014) Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula. Cancer Immunology, Immunotherapy 63:9, pages 959-967.
Crossref
Jitka Fucikova, Irena Moserova, Iva Truxova, Ivana Hermanova, Irena Vancurova, Simona Partlova, Anna Fialova, Ludek Sojka, Pierre-Francois Cartron, Milan Houska, Lukas Rob, Jirina Bartunkova & Radek Spisek. (2014) High hydrostatic pressure induces immunogenic cell death in human tumor cells. International Journal of Cancer 135:5, pages 1165-1177.
Crossref
Danielle A. de Verteuil, Alexandre Rouette, Marie-Pierre Hardy, Stéphanie Lavallée, Assya Trofimov, Étienne Gaucher & Claude Perreault. (2014) Immunoproteasomes Shape the Transcriptome and Regulate the Function of Dendritic Cells. The Journal of Immunology 193:3, pages 1121-1132.
Crossref
R.V. Dave, A.H.S. Jebar, V.A. Jennings, R.A. Adair, E.J. West, F. Errington-Mais, G.J. Toogood & A.A. Melcher. (2014) Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses. The Surgeon 12:4, pages 210-220.
Crossref
Iva Truxova, Katerina Pokorna, Kamila Kloudova, Simona Partlova, Radek Spisek & Jitka Fucikova. (2014) Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs. Immunology Letters 160:1, pages 39-49.
Crossref
John T. Wilson & Elliot L. Chaikof. 2014. Micro- and Nanoengineering of the Cell Surface. Micro- and Nanoengineering of the Cell Surface 281 314 .